-

02:33:00 PM

MYCOF Stock News

MYCOF - Mydecine Innovations Group Inc

08/30/23 4:01 PM

OTC : MYCOF

Mydecine Announces Conditional Approval of CSE Listing

Mydecine Innovations Group Inc. (NEO:MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), is pleased to announce that it has made an application and received conditional approval to list its common shares on the Canadian

RHEA-AI

positive

05/29/23 7:42 PM

OTC : MYCOF

management

Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreement and Provides Update on Its Board of Directors

Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with

RHEA-AI

neutral

05/10/23 4:05 PM

OTC : MYCOF

Mydecine Reports its 2023 Annual General Shareholders' Meeting Results

Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with

RHEA-AI

positive

04/24/23 11:16 AM

OTC : MYCOF

clinical trial

Mydecine Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting MDMA Analogues

Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health

RHEA-AI

positive

04/03/23 6:00 AM

OTC : MYCOF

Mydecine Innovations Group Provides Corporate Update

Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health

RHEA-AI

very positive

03/31/23 8:21 PM

OTC : MYCOF

earnings

Mydecine Reports Financial Results for the Year Ended December 2022

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported company highlights and financial results for

RHEA-AI

neutral

12/12/22 11:39 AM

OTC : MYCOF

Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health Inc.

Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address addiction and mental health, is pleased

RHEA-AI

neutral

11/14/22 5:44 PM

OTC : MYCOF

earnings

Mydecine Reports Financial Results for the Third Quarter of Fiscal Year 2022

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported company highlights and financial results for

RHEA-AI

neutral

09/01/22 10:00 AM

OTC : MYCOF

Mydecine Innovations Group Signs a Letter of Intent to Sell its Wholly-Owned Subsidiary, Mindleap Health Inc.

Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular

RHEA-AI

neutral

08/29/22 4:00 PM

OTC : MYCOF

Mydecine Innovations Group Announces Common Share Subscription Agreement

Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 Next